Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA3 | P07451 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | PLA2G7 | Q13093 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11323690 | 0.82 | HTR6 (0.55) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL15434593 | 0.78 | HTR6 (0.50) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL28841908 | 0.78 | ALDH1A1 (0.52) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL5166440 | 0.78 | HTR6 (0.50) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL11335316 | 0.78 | HTR6 (0.50) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL135257 | 0.76 | DNMT1 (0.56) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL7618702 | 0.76 | DUSP3 (0.48) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL11568829 | 0.72 | APOBEC3G (0.52) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL10583865 | 0.72 | HPGD (0.48) | HTR6ALDH1A1CA1CA2HSD17B10 | |
| SCHEMBL11291589 | 0.72 | PSIP1 (0.54) | HTR6ALDH1A1CA1CA2HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | WUYAN PHARMACEUTICAL TECHNOLOGY (SHANGHAI) CO., LTD (CN) | 2024-11-07 | — | — | US | claimed |
| CN-118490889-A | ROS (reactive oxygen species) responsive hydrogel as well as preparation method and application thereof | 华南理工大学 | 2024-08-16 | — | — | CN | claimed |
| CN-115650827-A | Preparation method, intermediate compound and synthesis method for anthracycline derivatives | 戊言医药科技（上海）有限公司 | 2023-01-31 | — | — | CN | claimed |
| CN-108863871-B | Pyrene derivative electroluminescent material and preparation method and application thereof | 华南协同创新研究院 | 2020-12-01 | — | — | CN | claimed |
| CN-103113387-B | The synthetic method of asymmetric two thieno-heteroaromatic compounds | HENAN UNIVERSITY (CN) | 2016-02-17 | — | — | CN | claimed |
| EP-1308540-B1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY CO LLC (US) | 2010-01-20 | — | — | EP | claimed |
| US-20040104124-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2004-06-03 | — | — | US | claimed |
| US-6736954-B2 | A METAL PLATING BATH COMPRISING METAL SALTS AND AN ADDITIVE CONSUMPTION INHIBITOR(A HETEROATOM ORGANIC COMPOUNDS WHICH MAY CONTAIN SULFUR, OXYGEN OR NITROGEN HETEROATOMS) IMPROVE THE BRIGHTNESS OF PLATED METAL AS WELL AS THE DUCTILITY | SHIPLEY COMPANY, L.L.C. | 2004-05-18 | — | — | US | claimed |
| EP-1308540-A1 | Plating bath and method for depositing a metal layer on a substrate | Shipley Co. L.L.C. (US) | 2003-05-07 | — | — | EP | claimed |
| US-20030070934-A1 | Plating bath and method for depositing a metal layer on a substrate | SHIPLEY COMPANY, L.L.C. | 2003-04-17 | — | — | US | claimed |
| WO-2025235763-A1 | FLUORESCENT PROBES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-11-13 | — | — | WO | disclosed |
| US-20250122226-A1 | GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES | NOVO NORDISK AS (DK) | 2025-04-17 | — | — | US | disclosed |
| US-12227528-B2 | Glucose-sensitive albumin-binding derivatives | NOVO NORDISK A/S (DK) | 2025-02-18 | — | — | US | disclosed |
| CN-118490889-A | ROS (reactive oxygen species) responsive hydrogel as well as preparation method and application thereof | 华南理工大学 | 2024-08-16 | — | — | CN | disclosed |
| CN-117624207-A | Glucose-sensitive albumin binding derivatives | 诺和诺德股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| WO-1997030069-A1 | 17-BETA-CYCLOPROPYL(AMINO/OXY) 4-AZA STEROIDS AS ACTIVE INHIBITORS OF TESTOSTERONE 5-ALPHA-REDUCTASE AND C17-20-LYASE | HOECHST MARION ROUSSEL, INC. (US) | 1997-08-21 | — | — | WO | disclosed |
| EP-0680466-A1 | PROCESS FOR PREPARING ISOCYANATES. | MONSANTO CO (US) | 1995-11-08 | — | — | EP | disclosed |
| CN-1099384-A | Process for preparing isocyanates | MONSANTO CO (US) | 1995-03-01 | — | — | CN | disclosed |
| US-5349081-A | Dehydration, primary amine and carbon dioxide | MONSANTO COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| WO-1994017032-A1 | PROCESS FOR PREPARING ISOCYANATES | MONSANTO COMPANY (US) | 1994-08-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12227528-B2 | Glucose-sensitive albumin-binding derivatives | ALB, DBI, FABP4 | HTR6 4018/4885ALDH1A1 1240/4885CA1 1665/4885 |
| US-20240368063-A1 | PREPARATION METHOD, INTERMEDIATE COMPOUNDS, AND SYNTHESIS METHOD FOR A CLASS OF ANTHRACENE-DERIVED TOXINS IN ORGANIC CHEMISTRY | ANTXR2, AKR7A2, ACR | HTR6 3877/4885ALDH1A1 1295/4885CA1 277/4885 |
| US-20250122226-A1 | GLUCOSE-SENSITIVE ALBUMIN-BINDING DERIVATIVES | ALB, DBI, FABP4 | HTR6 4018/4885ALDH1A1 1240/4885CA1 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.